Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women
Open Access
- 21 January 2019
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 8 (1) , 197-210
Abstract
The use of depot medroxyprogesterone acetate (DMPA), a 3-monthly injectable hormonal contraceptive, is associated with an increased risk of HIV acquisition possibly through alteration of the vaginal microbiome. In this longitudinal interventional study, we investigated the impact of DMPA administration on the vaginal microbiome in Hispanic White and Black women at the baseline (visit 1), 1 month (visit 2), and 3 months (visit 3) following DMPA treatment by using 16S rRNA gene sequencing. No significant changes in the vaginal microbiome were observed after DMPA treatment when Hispanic White and Black women were analysed as a combined group. However, DMPA treatment enriched total vaginosis-associated bacteria (VNAB) and Prevotella at visit 2, and simplified the correlational network in the vaginal microbiome in Black women, while increasing the network size in Hispanic White women. The microbiome in Black women became more diversified and contained more VNAB than Hispanic White women after DMPA treatment. While the Firmicutes to Bacteroidetes (F/B) ratio and Lactobacillus to Prevotella (L/P) ratio were comparable between Black and Hispanic White women at visit 1, both ratios were lower in Black women than in Hispanic White women at visit 2. In conclusion, DMPA treatment altered the community network and enriched VNAB in Black women but not in Hispanic White women. The Lactobacillus deficiency and enrichment of VNAB may contribute to the increased risk of HIV acquisition in Black women. Future studies on the impact of racial differences on the risk of HIV acquisition will offer insights into developing effective strategies for HIV prevention. Abbreviations: DMPA: depot medroxyprogesterone acetate; PCR: polymerase chain reaction; OTU: operational taxonomic unit; STI: sexually transmitted infections; VNAB: vaginosis-associated bacteriaKeywords
Funding Information
- National Institute of Dental and Craniofacial Research (R01CA204113ZB)
- National Institute of Dental and Craniofacial Research (U01CA182370ZB)
- National Cancer Institute
- Department of Veterans Affairs
- National Institutes of Health
- NYU School of Medicine
- NYU Langone Medical Center
- U.S. Department of Veterans Affairs
This publication has 57 references indexed in Scilit:
- A colorectal cancer classification system that associates cellular phenotype and responses to therapyNature Medicine, 2013
- Vaginal microbiome and sexually transmitted infections: an epidemiologic perspectiveJournal of Clinical Investigation, 2011
- Using network analysis to explore co-occurrence patterns in soil microbial communitiesThe ISME Journal, 2011
- In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxideBMC Infectious Diseases, 2011
- Diversity of 16S rRNA Genes within Individual Prokaryotic GenomesApplied and Environmental Microbiology, 2010
- Vaginal microbiome of reproductive-age womenProceedings of the National Academy of Sciences of the United States of America, 2010
- QIIME allows analysis of high-throughput community sequencing dataNature Methods, 2010
- Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the MicrobiomeGastroenterology, 2009
- Bacterial vaginosis and HIV acquisition: a meta-analysis of published studiesAIDS, 2008
- Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epitheliumObstetrics & Gynecology, 2000